Floatz logo

Ethylicum

Pancreatic Mucinous-Cystic Neoplasm

Samsung Medical CenterSmall moleculePhase 2Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Pancreatic Mucinous-Cystic Neoplasm cohort.

Asset / SponsorPhaseRating
Tamoxifen
University of Nebraska
Phase 1CC

Same molecule, other indications

Ethylicum is also rated in:

malignant pancreatic neoplasmDormant
BB
Indicative · Phase 4
66 / 100
View asset →
cancer-related conditionDormant
BB
Indicative · Phase 4
66 / 100
View asset →
leukemiaDormant
B
Indicative · Phase 4
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →